Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
Janusz Gumprecht(Medical University of Silesia), Stefan D. Anker(Bayer (Germany)), Ron T. Gansevoort(University Medical Center Groningen), Yoram Yagil(Ben-Gurion University of the Negev), George L. Bakris(Pennsylvania State System of Higher Education), Trine Finnes, Gerasimos Filippatos(National and Kapodistrian University of Athens), Giuseppe Remuzzi(Mario Negri Institute for Pharmacological Research), László Rosivall(Semmelweis University), Pantelis Sarafidis(Ippokrateio General Hospital of Thessaloniki), Christoph Wanner(Universitätsklinikum Würzburg), Cadena Bonfanti, Richard J. MacIsaac, Fernando González, Sheldon W. Tobe(Sunnybrook Health Science Centre), Martin Prázný, Magdalena Madero Rovalo, Luís M. Ruilope(Bayer (Germany)), Bertram Pitt(Bayer (Germany)), Theodora Temelkova‐Kurktschiev, Ellen Burgess, Adriaan Kooy, Guntram Schernthaner(Rudolfinerhaus Hospital), Roland E. Schmieder(Universitätsklinikum Erlangen), Meike Brinker(Bayer (Germany)), Charlie Scott(Bayer (United Kingdom)), Joseph A. Eustace(Johns Hopkins University), Daisuke Koya(Kanazawa Medical University), Pieter Gillard(Research Foundation - Flanders), Jorma Strand, Takashi Wada(FIND), Ehud Grossman(Tel Aviv University), Carlos Jaramillo, Peter Rossing(Steno Diabetes Centers), Michel Marre(Centre National de la Recherche Scientifique), Julio Wainstein(Wolfson Medical Center), Rajiv Agarwal(Richard L. Roudebush VA Medical Center), Juliana C.N. Chan(Chinese University of Hong Kong), Maria Eugênia Fernandes Canziani, Amer Joseph(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Andrés Ángelo, Froilan De Leon, Ellen Burgess(University of Calgary), Lothar Roessig(Bayer (Germany)), Augusto Vallejos
Cited by 36
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k